financetom
Business
financetom
/
Business
/
UK's Spectris rejects second KKR takeover approach in favour of Advent's $5 billion proposal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UK's Spectris rejects second KKR takeover approach in favour of Advent's $5 billion proposal
Jun 13, 2025 11:25 AM

(Reuters) -Britain's Spectris ( SEPJF ) said on Friday it has rejected a second takeover proposal from private equity firm KKR, days after the scientific instruments maker backed a possible competing $5 billion bid from Advent.

Spectris ( SEPJF ) did not provide details on KKR's proposal, noting only that it was the second proposal by the PE firm it had rejected.

The company, which provides hardware and software solutions to sectors such as pharmaceuticals, steel and automotive, said on Monday it would accept private equity firm Advent's proposal of 37.63 pounds per share if a formal offer was made.

Advent and KKR did not immediately respond to Reuters' requests for comment. The competing proposal by KKR was first reported by the Wall Street Journal on Friday.

Spectris ( SEPJF ) is the largest takeover target this year in Britain, a country that has attracted overseas buyers in recent years due to relatively cheap valuations.

Under UK takeover rules, KKR has until July 11 to make a formal offer or walk away.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Starbucks, Elliott in talks over on a settlement, CNBC reports
Starbucks, Elliott in talks over on a settlement, CNBC reports
Aug 12, 2024
Aug 12 (Reuters) - Starbucks ( SBUX ) and activist investor Elliott Management are talking about a settlement, CNBC reported on Monday, citing sources. ...
Taoping Says July Total Contract Revenue Value Rises 30%
Taoping Says July Total Contract Revenue Value Rises 30%
Aug 12, 2024
09:15 AM EDT, 08/12/2024 (MT Newswires) -- Taoping ( TAOP ) said Monday that its total contract revenue value rose 30% in July from a year earlier to about 27.4 million Chinese renminbi ($3.8 million). The technology company attributed the increase to strong demand for its artificial intelligence-based products. Taoping ( TAOP ) shares were nearly 9% higher in premarket...
Bird Construction Selected for Five Projects Exceeding $575 Million
Bird Construction Selected for Five Projects Exceeding $575 Million
Aug 12, 2024
09:19 AM EDT, 08/12/2024 (MT Newswires) -- Bird Construction ( BIRDF ) , whose shares jumped 3.7% on Friday, said on Monday that it has been selected for five projects with a combined value of more than $575 million. These include multi-year mine infrastructure work in Eastern Canada and three long-term care projects and a multi-building institutional project in Western...
Delay Hits Humacyte's Bioengineered Human Tissue Implant For Vascular Trauma Injuries, FDA Extends Time To Review
Delay Hits Humacyte's Bioengineered Human Tissue Implant For Vascular Trauma Injuries, FDA Extends Time To Review
Aug 12, 2024
Friday, the FDA announced it would require additional time to complete its review of Humacyte Inc.’s Biologic License Application (BLA) for the acellular tissue-engineered vessel (ATEV) in the vascular trauma indication. The ATEV trauma program BLA was submitted to the FDA in December 2023, and the FDA granted a Priority Review in February 2024 and assigned a PDUFA date of...
Copyright 2023-2025 - www.financetom.com All Rights Reserved